UNSPSC 51313105: Hydroxyzine embonate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C21H27ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 30S50YM8OG, chemically known as ethanol, 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)- but generally known as hydroxyzine, which bears US NIH Compound Identifier 3658. European Medicines Agency schedules Hydroxyzine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08088MIG.

UNSPSC 51313105 Hydroxyzine embonate is a Commodity code covering a specific pharmaceutical active ingredient, but the recent state and local procurement activity tagged under this code does not reflect actual purchases of hydroxyzine embonate itself. Instead, Seminole County, Florida posted an IFB on June 30, 2026 for naloxone and drug deactivation systems—opioid-reversal medication and harm-reduction equipment unrelated to hydroxyzine embonate in therapeutic intent, formulation, or use case. This mismatch suggests either a data-entry error in the UNSPSC tagging or a procurement system misconfiguration on the county's side. State and local governments do procure pharmaceuticals and medical supplies through formal competitive bidding, but this particular opportunity does not represent genuine market activity for hydroxyzine embonate at the state or local level.

The Seminole County IFB illustrates the structure of state and local pharmaceutical and medical-equipment procurement: competitive sealed bidding through e-Procurement portals, quarterly delivery schedules to fixed locations, inclusion of shipping and delivery costs in vendor pricing, E-Verify and drug-free workplace compliance, fixed-fee pricing, and multi-year terms with renewal options. However, because the available recent-opportunities data shows no actual hydroxyzine embonate solicitations, no geographic pattern or issuing-body mix can be reliably characterized for this code. The single posted opportunity is a poor fit for this Commodity code's nominal scope, leaving no actionable market signal for business development professionals pursuing hydroxyzine embonate contracts with state and local agencies.